PEG3 and Anxiety: These effects on sociability were also found in Laugeray et al. [43], who exposed rodents to GLA from early gestational ages to PND14 in a range of doses from 0.2 to 1 mg/kg/day, finding a significant decrease in USVs and social interaction rates following the highest dose (without affecting anxiety-state levels), along with several molecular outcomes such as a reduction in both Pten and Peg3 brain genes, which are commonly associated with ASD.